MarketPeel
Insider Trading Intelligence
Pricing
…
JL

John L. Lamattina

LGND
DIRECTOR · LIGAND PHARMACEUTICALS INC · CIK 0001216074
FILING MIX · LIFETIME64%/36%
BUYS
29
SELLS
16
TOTAL VALUE
$4.50M
COMPANIES
2
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
33,469
AVG SELL PX
$193.94
TRADE KIND
SHOWING 45 / 45
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 8 pending
Forward-return performance of every backtestable P/S trade by John L. Lamattina, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+85.71%+3.13%+0.04%+3.09%-0.38%—
14d7+71.43%-0.09%-1.02%+0.93%+0.59%—
30d7+57.14%-7.68%+0.45%-8.13%-10.60%—
60d7+57.14%-4.61%+3.46%-8.07%-6.30%—
90d7+57.14%-10.37%+1.59%-15.98%-12.89%—
180d7(1 pending)+33.33%-7.61%+4.85%-12.46%-17.50%—
1y7(3 pending)+25.00%-36.48%-2.45%-34.03%-56.58%—
2y7(4 pending)+33.33%-67.33%+0.34%-67.68%-69.74%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LGND · 26,969 shares · as of Jun 10, 2026
08,22116,44324,66432,885202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 29 buys / 16 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LGND
LIGAND PHARMACEUTICALS INC
SALE
3,405$251.62$856.8K26,969Jun 10, 2026Jun 12, 2026 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
232$248.11$57.6K31,071Jun 10, 2026Jun 12, 2026 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
257$247.22$63.5K31,303Jun 10, 2026Jun 12, 2026 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
697$249.53$173.9K30,374Jun 10, 2026Jun 12, 2026 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
836——31,560Jun 5, 2026Jun 9, 2026 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,938——2,938Jun 5, 2026Jun 9, 2026 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,161——0Mar 6, 2026Mar 31, 2026 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
2,161$114.15$246.7K32,885Mar 6, 2026Mar 31, 2026 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,161$200.76$433.8K30,724Mar 6, 2026Mar 31, 2026 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,034——0Nov 7, 2025Nov 12, 2025 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,145——0Nov 7, 2025Nov 12, 2025 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
2,145$66.13$141.8K32,869Nov 7, 2025Nov 12, 2025 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,034$205.45$417.9K30,724Nov 7, 2025Nov 12, 2025 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,145$205.45$440.7K30,724Nov 7, 2025Nov 12, 2025 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
2,034$69.51$141.4K32,758Nov 7, 2025Nov 12, 2025 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,209——30,724Jun 6, 2025Jun 10, 2025 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,783——5,783Jun 6, 2025Jun 10, 2025 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,406——0Nov 27, 2024Dec 2, 2024 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,406$123.65$297.5K29,515Nov 27, 2024Dec 2, 2024 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
2,406$52.30$125.8K31,921Nov 27, 2024Dec 2, 2024 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,444——5,444Jun 14, 2024Jun 18, 2024 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,252——29,515Jun 14, 2024Jun 18, 2024 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,142——28,263Jun 9, 2023Jun 13, 2023 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,461——5,461Jun 9, 2023Jun 13, 2023 ↗View →
IMNM
IMMUNOME INC.
PURCHASEGRANT
Stock grant
6,500——6,500Jun 8, 2023Jun 12, 2023 ↗View →
IMNM
IMMUNOME INC.
PURCHASEGRANT
Stock grant
15,125$4.00$60.5K66,953Jan 15, 2023Jan 17, 2023 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,484——4,484Dec 22, 2022Dec 27, 2022 ↗View →
IMNM
IMMUNOME INC.
PURCHASEGRANT
Stock grant
6,500——6,500Jun 16, 2022Jun 21, 2022 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,340——4,340Jun 10, 2022Jun 13, 2022 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,004——26,402Jun 10, 2022Jun 13, 2022 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
4,835$32.30$156.2K30,233Nov 16, 2021Nov 17, 2021 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
4,835——0Nov 16, 2021Nov 17, 2021 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
4,835$161.86$782.6K25,398Nov 16, 2021Nov 17, 2021 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
630——25,398Jun 4, 2021Jun 7, 2021 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
3,269——3,269Jun 4, 2021Jun 7, 2021 ↗View →
IMNM
IMMUNOME INC.
PURCHASEGRANT
Stock grant
3,750——3,750May 28, 2021Jun 1, 2021 ↗View →
IMNM
IMMUNOME INC.
PURCHASE
5,102$18.58$94.8K51,828May 24, 2021May 26, 2021 ↗View →
IMNM
IMMUNOME INC.
PURCHASE
338$18.44$6.2K46,726May 24, 2021May 26, 2021 ↗View →
IMNM
IMMUNOME INC.
PURCHASEGRANT
Stock grant
7,500——7,500Nov 3, 2020Nov 5, 2020 ↗View →
IMNM
IMMUNOME INC.
PURCHASE
11,111——11,111Oct 6, 2020Oct 8, 2020 ↗View →
IMNM
IMMUNOME INC.
PURCHASE
46,388——46,388Oct 6, 2020Oct 8, 2020 ↗View →
IMNM
IMMUNOME INC.
SALE
46,388——0Oct 6, 2020Oct 8, 2020 ↗View →
IMNM
IMMUNOME INC.
SALE
11,111——0Oct 6, 2020Oct 8, 2020 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,468——2,468Jun 10, 2020Jun 12, 2020 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
831——24,768Jun 10, 2020Jun 12, 2020 ↗View →
Other insiders · LGND
Loading peer insiders…
About this filer
CIK 0001216074
ROLE
Director
PRIMARY
LGND
COMPANIES
2
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001216074DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback